Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin

Details for Australian Patent Application No. 2006315766 (hide)

Owner Colorado State University Research Foundation

Inventors Ishii, Douglas N.

Agent EF WELLINGTON & CO

Pub. Number AU-A-2006315766

PCT Pub. Number WO2007/058902

Priority 60/735,606 11.11.05 US

Filing date 10 November 2006

Wipo publication date 24 May 2007

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 June 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Ishii, Douglas N.

12 June 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 19 May 2008

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/058902 Priority application(s): WO2007/058902

17 July 2008 Alteration of Name

  The name of the applicant has been altered to Aurogen Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315775-Nasal and oral cannula having three or more capabilities and method of producing same

2006315760-Materials and methods for ABCB1 polymorphic variant screening, diagnosis, and treatment